Synthesis of 2′-deoxy-2′-fluoro-2′-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase

2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants

(2018) Uma S. Singh et al.   MEDICINAL RESEARCH REVIEWS

Synthesis of an Anti-hepatitis B Agent, 2′-Fluoro-6′-methylene-carbocyclic Adenosine (FMCA) and Its Phosphoramidate (FMCAP)

(2018) Uma S. Singh et al.   JOURNAL OF ORGANIC CHEMISTRY

The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C

(2015) Ivan Gentile et al.   Expert Opinion on Drug Discovery

Recent progress for the synthesis of selected carbocyclic nucleosides

(2015) Maxime Bessières et al.   Future Medicinal Chemistry

Stereoselective Synthesis of 2′-Fluoro-6′-methylene Carbocyclic Adenosine via Vince Lactam

(2014) Uma S. Singh et al.   JOURNAL OF ORGANIC CHEMISTRY

2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action

(2012) Ravindra K. Rawal et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

2′-Deoxy-2′-spirocyclopropylcytidine Revisited: A New and Selective Inhibitor of the Hepatitis C Virus NS5B Polymerase

(2010) Tim H. M. Jonckers et al.   JOURNAL OF MEDICINAL CHEMISTRY

Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus

(2010) Michael J. Sofia et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pegylated interferon and ribavirin treatment for hepatitis C virus infection

(2010) Emilio Palumbo   Therapeutic Advances in Chronic Disease